Acute Kidney Injury in Patients with Newly Diagnosed High-Grade Hematological Malignancies: Impact on Remission and Survival

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Canet, Emmanuel ^a   Zafrani, Lara ^a   Lambert, Jerome ^a   Thieblemont, Catherine ^a   Galicier, Lionel ^a   Schnell, David ^a   Raffoux, Emmanuel ^a   Lengline, Etienne ^a   Chevret, Sylvie ^a,c   Darmon, Michael ^b   Azoulay, Elie ^a,c  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; METHOTREXATE; OXALIPLATIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HEMOPHAGOCYTIC SYNDROME; HODGKIN DISEASE; HUMAN; KIDNEY PERFUSION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; RENAL REPLACEMENT THERAPY; SURVIVAL TIME; TASK PERFORMANCE; TUMOR LYSIS SYNDROME;

ACUTE KIDNEY INJURY; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REMISSION INDUCTION; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84874008072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055870     Document Type: Article

References (43)

1. National Cancer Institute website. Available: http://www.seer.cancer.gov/csr/1975_2008/. Accessed 2013 Jan 21.
2. Cheson BD, Leonard JP, (2008) Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. N Engl J Med 359: 613-626.
3. Pulte D, Gondos A, Brenner H, (2009) Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 113: 1408-1411.
4. Galicier L, Fieschi C, Borie R, Meignin V, Daniel MT, et al. (2007) Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Blood 110: 2846-2854.
5. Sanz MA, Lo-Coco F, (2011) Modern approaches to treating acute promyelocytic leukemia. J Clin Oncol 29: 495-503.
6. Khassawneh BY, White P Jr, Anaissie EJ, Barlogie B, Hiller FC, (2002) Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 121: 185-188.
7. Lameire NH, Flombaum CD, Moreau D, Ronco C, (2005) Acute renal failure in cancer patients. Ann Med 37: 13-25.
8. Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, et al. (2006) Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 24: 4003-4010.
9. Darmon M, Thiery G, Ciroldi M, Porcher R, Schlemmer B, et al. (2007) Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med 33: 765-772.
10. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW, (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370.
11. Ostermann M, Chang RW (2007) Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 35: 1837-1843; quiz 1852.
12. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, (2004) Acute renal failure- definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204-212.
13. Bagshaw SM, George C, Dinu I, Bellomo R, (2008) A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 23: 1203-1210.
14. Thiery G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, et al. (2005) Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 23: 4406-4413.
15. Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA, (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 31: 104-112.
16. Bellomo R, Ronco C (1998) Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney Int Suppl 66: S106-109.
17. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, et al. (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25: 579-586.
18. Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, et al. (2003) Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 21: 4642-4649.
19. McGregor S, McNeer J, Gurbuxani S, (2012) Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia. Semin Diagn Pathol 29: 2-11.
20. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, et al. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710.
21. R Development Core Team website. Available: http://www.R-project.org/. Accessed 2013 Jan 21.
22. Lecuyer L, Chevret S, Guidet B, Aegerter P, Martel P, et al. (2008) Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 32: 748-754.
23. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. (2007) Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 33: 1563-1570.
24. Benoit DD, Hoste EA, (2010) Acute kidney injury in critically ill patients with cancer. Crit Care Clin 26: 151-179.
25. Howard SC, Jones DP, Pui CH, (2011) The tumor lysis syndrome. N Engl J Med 364: 1844-1854.
26. Buemi M, Fazio MR, Bolignano D, Coppolino G, Donato V, et al. (2009) Renal complications in oncohematologic patients. J Investig Med 57: 892-901.
27. Karras A, (2009) What nephrologists need to know about hemophagocytic syndrome. Nat Rev Nephrol 5: 329-336.
28. Thaunat O, Delahousse M, Fakhouri F, Martinez F, Stephan JL, et al. (2006) Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int 69: 1892-1898.
29. Buyse S, Teixeira L, Galicier L, Mariotte E, Lemiale V, et al. (2010) Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 36: 1695-1702.
30. Janka GE, (2005) Hemophagocytic lymphohistiocytosis. Hematology 10Suppl 1: 104-107.
31. Benoit DD, Hoste EA, Depuydt PO, Offner FC, Lameire NH, et al. (2005) Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant 20: 552-558.
32. Parikh CR, Coca SG, (2006) Acute renal failure in hematopoietic cell transplantation. Kidney Int 69: 430-435.
33. Mead GM, Sydes MR, Walewski J, Grigg A, Hatton CS, et al. (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 13: 1264-1274.
34. Mead GM, Barrans SL, Qian W, Walewski J, Radford JA, et al. (2008) A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood 112: 2248-2260.
35. Blum KA, Lozanski G, Byrd JC, (2004) Adult Burkitt leukemia and lymphoma. Blood 104: 3009-3020.
36. Schafer ES, Hunger SP, (2011) Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults. Nat Rev Clin Oncol 8: 417-424.
37. Bassan R, Hoelzer D, (2011) Modern therapy of acute lymphoblastic leukemia. J Clin Oncol 29: 532-543.
38. Smeland S, Blystad AK, Kvaloy SO, Ikonomou IM, Delabie J, et al. (2004) Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens. Ann Oncol 15: 1072-1078.
39. Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, et al. (2005) AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23: 4430-4438.
40. Azoulay E, Pochard F, Chevret S, Vinsonneau C, Garrouste M, et al. (2001) Compliance with triage to intensive care recommendations. Crit Care Med 29: 2132-2136.
41. Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, et al. (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 182: 1038-1046.
42. Lengline E, Raffoux E, Lemiale V, Darmon M, Canet E, et al. (2012) Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma.
43. Legrand M, Max A, Peigne V, Mariotte E, Canet E, et al. (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40: 43-49.